Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Chemoprotective properties of lisofylline reported

Dec. 18, 1997

Indomethacin: antitumor activity and effects on telomerase

Dec. 17, 1997

Clinical evaluation of adenoviral-p53 gene therapy for prostate cancer begins

Dec. 17, 1997

Burzynski's antineoplastons in phase II testing for multiple oncology indications

Dec. 17, 1997

Neovascularization inhibitors from Tsumura Juntendo

Dec. 17, 1997

Farnesyltransferase inhibitors claimed by Banyu

Dec. 17, 1997

Aronex presents preliminary phase II results on Atragen

Dec. 16, 1997

Second-generation antisense antitumor compound from Hybridon enters clinic

Dec. 16, 1997

Total synthesis of aglaiastatin C, a natural antitumor alkaloid

Dec. 15, 1997

New FPP-based inhibitor of protein farnesyltransferase discovered at Banyu

Dec. 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...